Intellectual Property India Publishes Patent Application for 'Compositions And Methods For Genomic Editing' Filed by Intellia Therapeutics, Inc.

MUMBAI, India, Feb. 28 -- Intellectual Property India has published a patent application (202517003126 A) filed by Intellia Therapeutics, Inc., Cambridge, U.S.A., on Jan. 14, for 'compositions and methods for genomic editing.'

Inventor(s) include Oliveira, Ruan; Choi, Sung Hee; Liu, Biao; and Barve, Radhika.

The application for the patent was published on Feb. 28, under issue no. 09/2025.

According to the abstract released by the Intellectual Property India: "Compositions and methods for ex vivo genomic editing using Neisseria meningitidis (Nme) CRISPR/Cas9 systems are disclosed. The present disclosure provides for engineered cells comprising a genetical modification for use e.g., in adoptive cell transfer therapies."

The patent applica...